loading...| Preferred Name |
Hyaluronidase |
|
| Synonyms |
|
|
| Definitions |
An injectable enzyme with potential adjuvant activity. Upon subcutaneous administration, hyaluronidase modifies the permeability of connective tissue by hydrolyzing hyaluronic acid. This temporarily decreases interstitial viscosity and allows drugs that are co-injected to spread rapidly through the interstitial space, thereby facilitating absorption and/or distribution of the co-injected agents. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C87576 |
|
| CAS_Registry |
9001-54-1 |
|
| code |
C87576 |
|
| Contributing_Source |
FDA |
|
| definition |
An injectable enzyme with potential adjuvant activity. Upon subcutaneous administration, hyaluronidase modifies the permeability of connective tissue by hydrolyzing hyaluronic acid. This temporarily decreases interstitial viscosity and allows drugs that are co-injected to spread rapidly through the interstitial space, thereby facilitating absorption and/or distribution of the co-injected agents. |
|
| FDA_UNII_Code |
8KOG53Z5EM |
|
| in_subset | ||
| label |
Hyaluronidase |
|
| Preferred_Name |
Hyaluronidase |
|
| prefixIRI |
NCIT:C87576 |
|
| prefLabel |
Hyaluronidase |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0020197 |
|
| subClassOf |